Literature DB >> 12402663

[Probiotics: history, definition, requirements and possible therapeutic applications].

Massimo Montalto1, Fabiola Arancio, Donatello Izzi, Lucio Cuoco, Valentina Curigliano, Raffaele Manna, Giovanni Gasbarrini.   

Abstract

The ingestion of probiotics is associated with various beneficial effects on human health and modifies the physiological homeostasis of the intestinal flora. Probiotics are microorganisms with some particular characteristics: human origin, safety in human use, bile and acid resistance, survival in the intestine, at least temporary colonization of the human gut, adhesion to the mucosa and bacteriocine production. Thanks to these characteristics, probiotics block the invasion of human intestinal cells by the enteroinvasive bacteria. Furthermore, they should be able to stimulate and modulate the intestinal immune response, and to protect and stabilize the mucosal barrier. Finally, the efficacy of probiotics should be evident and documented with valid studies. All their properties should be maintained during processing and storage. Probiotics are usually used to protect the host from pathogens. With regard to this, they are useful in the prevention of antibiotic and traveler's diarrhea and they may play a role in the management of gastric Helicobacter pylori infection. Furthermore, their efficacy in the treatment of infectious diarrhea, in inflammatory bowel diseases, in pouchitis and in food allergy has been shown. Probiotics can improve the symptoms of irritable bowel syndrome and of lactose malabsorption. Finally, it has been suggested that such microorganisms may play a role in the prevention of carcinogenesis and of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402663

Source DB:  PubMed          Journal:  Ann Ital Med Int        ISSN: 0393-9340


  4 in total

1.  Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

Authors:  T Kühbacher; S J Ott; U Helwig; T Mimura; F Rizzello; B Kleessen; P Gionchetti; M Blaut; M Campieri; U R Fölsch; M A Kamm; S Schreiber
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

2.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

3.  MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage.

Authors:  Shintaro Ichikawa; Mika Miyake; Rei Fujii; Yutaka Konishi
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

4.  Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial.

Authors:  Anju Sinha; Subodh S Gupta; Harish Chellani; Chetna Maliye; Vidya Kumari; Sugandha Arya; B S Garg; Sunita Dixit Gaur; Rajni Gaind; Vijayshri Deotale; Manish Taywade; M S Prasad; Vasantha Thavraj; Ajit Mukherjee; Malabika Roy
Journal:  BMJ Open       Date:  2015-07-10       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.